White House proposes to 'march in' on patents for costly drugs To lower drug prices, the Biden administration is looking to assert ...
White House proposes to 'march in' on patents for costly drugs
To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.
Read more on NPR
To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.
Read more on NPR
